An upset in the body's natural balance of gut bacteria that may lead to life-threatening bloodstream infections can be reversed by enhancing a specific immune defense response, UT Southwestern Medical Center researchers have found. In the study, published online in Nature Medicine, scientists identified how a certain transcription factor -- a protein that that turns genes on and off -- works in partnership with a naturally occurring antibiotic to kill infection-causing fungi called Candida albicans.
Research assistant Laura Coughlin, seated, Dr. Andrew Koh, and Dr. Tiffany Simms-Waldrep use an anaerobic chamber as part of a study investigating how the gut's bacteria defense system fights off Candida albicans infection. Photo courtesy of UT Southwestern
An upset in the body's natural balance of gut bacteria that may lead to life-threatening bloodstream infections can be reversed by enhancing a specific immune defense response, UT Southwestern Medical Center researchers have found. In the study, published online in Nature Medicine, scientists identified how a certain transcription factor -- a protein that turns genes on and off -- works in partnership with a naturally occurring antibiotic to kill infection-causing fungi called Candida albicans.
These particular fungi, best known as a cause of yeast infections and oral thrush, can be lethal if they overgrow and invade the bloodstream from the gut. At high risk for this type of infection are stem cell transplant and leukemia patients whose immune systems are suppressed during treatment. Up to 25 percent of cancer patients develop bloodstream infections from bacteria or fungi.
"For a cancer patient with a Candida bloodstream infection, the fatality rate is about 30 percent. Candida is the No. 1 fungal pathogen," says senior author Dr. Andrew Koh, assistant professor of pediatrics and microbiology, and a member of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern.
Certain antibiotics do fight invasive Candida infection, but they are not always effective and antibiotic resistance increasingly has become an issue. Koh's research team aimed to uncover how the body's natural immune defense system might be enhanced to fight a Candida infection.
About half of the population carries Candida in the gut, where the yeast is usually harmless. When the organism overgrows, it may leave the gut and cause infection. Commensal bacteria, the resident bacteria of the gut, normally defend against disease by inhibiting growth of potentially pathogenic organisms.
By studying how mice infected with Candida responded in different scenarios, the researchers discovered how to enhance the body's natural ability to eradicate infection, in this case Candida.
"The commensal bacteria stimulate gut tissue to make a transcription factor and a natural antibiotic, which then kills the Candida fungus," says Koh, director of the pediatric hematopoietic stem cell transplantation program at UT Southwestern and Children's Medical Center Dallas. "When we gave the mice a pharmacologic agent called L-mimosine that stimulates the transcription factor, the agent knocked down Candida 100-fold, which translated into a 50 percent reduction in mortality from invasive Candida infection."
Specifically, the researchers found that enhancing the transcription factor HIF-1α with L-mimosine led to increased production of the natural antibiotic peptide LL-37, which in turn killed the fungi. L-mimosine is a natural product derived from seeds of the koa haole tree that is not approved as a drug but is known to boost HIF-1α activity. The study also suggested that certain gut bacteria -- Cloistridial Firmicutes and Bacteroidetes -- may be important in producing short-chain fatty acids that help fight infection.
More study is needed to pinpoint the optimal method of inducing the body's gut defense system, whether through use of an agent like L-mimosine or by administering short-chain fatty acids such as vinegar.
"Can we modulate the gut system to maintain balance so that it never gets to the point of pathogens invading the bloodstream?" asks Koh. "Boosting GI mucosal immune effectors to reduce fungal burden may be the key to tipping the balance back toward normal and preventing invasive fungal disease."
Study lead author Di Fan formerly worked in Koh's lab. Other contributing authors were Laura Coughlin, research assistant in pediatrics; Jiwoong Kim and Minsoo Kim, computational biologists in clinical sciences; Dr. Xiaowei Zhan, assistant professor of clinical science and in the Center for the Genetics of Host Defense; Dr. Tiffany Simms-Waldrip, assistant professor of Ppediatrics and member of the Pediatric Hematopoietic Stem Cell Transplantation Program; Dr. Yang Xie, associate professor of clinical science; and Dr. Lora Hooper, professor of immunology and microbiology, and in the Center for the Genetics of Host Defense. Hooper, a Howard Hughes Medical Institute (HHMI) Investigator, holds the Jonathan W. Uhr, MD, Distinguished Chair in Immunology and is Nancy Cain and Jeffrey A. Marcus Scholar in Medical Research, in Honor of Dr. Bill S. Vowel.
The research was funded by the National Institutes of Health, the Howard Hughes Medical Institute, the Roberta I. and Norman L. Pollock Fund, and a Global Probiotics Council Young Investigator Grant for Probiotics.
UT Southwestern's Harold C. Simmons Comprehensive Cancer Center includes 13 major cancer care programs with a focus on treating the whole patient with innovative treatments, while fostering groundbreaking basic research that has the potential to improve patient care and prevention of cancer worldwide. In addition, the Center's education and training programs support and develop the next generation of cancer researchers and clinicians.
Source: UT Southwestern Medical Center